Nintx
São Paulo, Brazil · Biotechnology, Health Care, Pharmaceutical
Nintx develops a new generation of medicines leveraging biodiversity, primarily from Brazil. One of its key innovations is a broader approach to tackling multifactorial diseases, caused by genetic and environmental factors as well as their interactions via the human gut microbiome. Multifactorial diseases include metabolic, immunological, cancer, and brain disorders. Nintx develops therapies targe
Key facts
- Headquarters
- São Paulo, Brazil
- Employees
- 13
- Industries
- Biotechnology, Health Care, Pharmaceutical
- Status
- Private
- Website
- nintx.com.br
- Company page
Recent activity at Nintx
- : Nintx Appoints Stephani Saverio as CEO and Restructures Leadership Team
- : Nintx Raises US$ 10 Million to Advance New Generation of Medicines Based on Brazilian Biodiversity
- : Nintx raised $10 million in a Series A round led by Pitanga, Ecoa Capital, and MOV Investimentos to advance R&D for new drug programs utilizing Brazilian biodiversity.
Nintx funding history
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Series A | $10.0M |
Leadership
- Stephani Saverio, Chief Executive Officer
- Cristiano Guimarães, Chief Scientific Officer
- Miller Freitas, Chief Development Officer
Verified email and direct lines for Nintx’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Nintx in the news
- Biotech Nintx Raises US$ 10 Million to Advance a New Generation of Medicines Based on Brazilian Biodiversity - BioSpace (Dec 13, 2024)
- The Amazon in the Limelight: An Opportunity for Biotech in Brazil - Genetic Engineering and Biotechnology News (Mar 13, 2023)
- Biotech startup aims to transform Brazilian biodiversity’s natural products into innovative therapies - Agência FAPESP (May 03, 2023)
Companies similar to Nintx
- Lavior Pharma · Biotechnology, Health Care, Pharmaceutical
- LTR Pharma Limited · Biotechnology, Health Care, Pharmaceutical
- Autotelic Bio · Biotechnology, Health Care, Pharmaceutical
- TNF Pharmaceuticals · Biotechnology, Health Care, Pharmaceutical
- Sagimet · Biotechnology, Health Care, Pharmaceutical
About Nintx: questions and answers
What does Nintx do?
Nintx develops a new generation of medicines leveraging biodiversity, primarily from Brazil. One of its key innovations is a broader approach to tackling multifactorial diseases, caused by genetic and environmental factors as well as their interactions via the human gut microbiome. Multifactorial diseases include metabolic, immunological, cancer, and brain disorders. Nintx develops therapies targe
Where is Nintx headquartered?
Nintx is headquartered in São Paulo, Brazil.
How many employees does Nintx have?
Nintx has about 13 employees.
Has Nintx raised funding?
Yes. Fundz has recorded 1 funding event for Nintx. The most recent, Series A of $10.0M, was in Dec 2024.
Who leads Nintx?
Stephani Saverio is a Chief Executive Officer at Nintx.
What is the latest news on Nintx?
On Dec 13, 2024, Nintx Appoints Stephani Saverio as CEO and Restructures Leadership Team
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy